Myriad Genetics Applauds New Guidelines Recommending Screening for Chromosomal Abnormalities

(marketscreener.com) Myriad Genetics continues to advance non-invasive prenatal screening with Prequel® and the forthcoming FirstGene™ test using AMPLIFY™ technology SALT LAKE CITY, Jan. 05, 2023 -- Myriad Genetics, Inc., , a leader in genetic testing and precision medicine, today announced its support for a recent guideline update by the American...https://www.marketscreener.com/quote/stock/MYRIAD-GENETICS-INC-10141/news/Myriad-Genetics-Applauds-New-Guidelines-Recommending-Screening-for-Chromosomal-Abnormalities-42665037/?utm_medium=RSS&utm_content=20230105